Latest Regulatory News

Kinetiko Energy has secured the first tranche of funding from FFS Refiners to accelerate development of a pilot LNG gas plant at Brakfontein, marking a key step in its multi-phase Project Alpha.

Imagion Biosystems reports encouraging findings from its Wayne State University collaboration, supporting a lower dose for its MagSense® HER2 imaging agent ahead of a planned FDA IND submission in Q4 2025.

KALiNA Power’s Canadian arm has completed a CAD$18 million transfer of allocated megawatts to Greenlight and its global data centre client, marking a significant milestone in its Alberta power projects.

Taiton Resources has secured regulatory approval to launch its first-ever drilling campaign at the Challenger West project in South Australia, targeting promising gold anomalies near a major existing mine.

QBE Insurance Group has priced a $300 million issue of USD subordinated notes due in 2037, offering investors a fixed 5.239% interest rate initially, with a reset in 2032 tied to U.S. Treasury yields. These notes strengthen QBE’s regulatory capital under APRA’s framework.

Far East Gold has secured a pivotal PIPPIB approval for 9,000 hectares of its Idenburg Gold Project in Papua, Indonesia, clearing a major regulatory hurdle and accelerating its path toward mine development.

Orthocell has appointed a second Canadian distributor for its nerve repair device Remplir™, achieving full national coverage and setting the stage for initial sales this quarter.

Hansen Technologies has agreed to acquire UK-based Digitalk for approximately A$66.4 million, aiming to boost its recurring revenue and global communications footprint. The deal is expected to be immediately accretive to earnings and completed by year-end 2025.

TrivarX Limited has exercised its option to acquire the innovative Stabl-Im brain imaging technology, aiming to revolutionize early detection of brain tumours pending shareholder approval.

Tivan Limited has secured six new exploration licenses in Timor-Leste, boosting its critical minerals portfolio with copper, cobalt, and gold prospects. The $500,000 deal complements its existing Turiscai Project and positions the company for accelerated exploration in a largely untapped region.

PEXA Group reported a robust first quarter for FY26, driven by refinancing growth in Australia and rising momentum in the UK market. The company reaffirmed its full-year guidance while advancing key strategic initiatives including platform modernization and a NatWest partnership.

Challenger Limited has provided a detailed update on APRA’s proposed capital standards, highlighting enhanced capital strength and strategic growth opportunities in the life insurance sector.